Table 1.
Fibrin-Based Material Description |
Targeted Biomedical Application |
Wound Type | Type of Cells Used | Animal Models | Clinical Application |
Bio-Mechanical Tests | Comments | Reference |
---|---|---|---|---|---|---|---|---|
Pure fibrin gel | Skin substitute | Burn | Human keratinocytes | n/a | Yes | n/a | 3-year patient follow up | [104] |
Fibrin–succinimidyl glutarate blends | Skin-on-chip/skin reconstruction | Toxic wounds | Fibroblasts and keratinocytes | n/a | n/a | Permeation and swelling tests | Good potential for wound healing | [105] |
Platelet-rich fibrin | Diabetic foot ulcers | Diabetic skin wound | n/a | Male nude mice | n/a | n/a | Promoting angiogenesis | [106] |
Leukocyte- and platelet-rich fibrin | Scalp Defect Reconstruction | Surgical open wounds | n/a | n/a | Yes | n/a | Effective toward skin malignancy on the scalp | [107] |
Collagen hydrogel/fibrin-coated polylactide | Skin repair | Deep skin wounds | Fibroblasts | n/a | n/a | n/a | Keratinocytes formed basal layers | [108] |
Poly(ethylene glycol)–fibrinogen conjugates | Tissue engineering | n/a | Smooth muscle cells | n/a | n/a | Stress–sweep rheological testing | Cell proliferation control with fibrin nano-fibers | [109] |
Fibrin hydrogel | Skin substitutes | Subcutaneous replacement | Adipose-derived stem cells (ASCs) and mature adipocytes | n/a | Patients undergoing body contouring surgery | n/a | Artificial hypodermis similar to native adipose tissue | [110] |
Fibrin membrane | Skin scaffolds | Diabetic wound regeneration | Fibroblasts | Diabetic rats | n/a | n/a | Good collagen deposition in the wounds | [111] |
Platelet-rich fibrin | Excisions of skin cancers | Dermatologic surgery | n/a | n/a | Patient with multiple nonmelanoma skin cancer. | n/a | Exuberant granulation tissue formation over ulcers | [112] |
Leukocyte–Platelet-Rich Fibrin | Skull defect reconstruction | Endoscopic skull base surgery | n/a | n/a | Patients underwent endoscopic endonasal resection | n/a | Healthy crust formation occurred | [113] |
Collagen–fibrin–polyethylene glycol (PEG) scaffolds | Vascular skin reconstruction | Burn-induced wound debridement | Stem cells from adipose tissue layer | Athymic rats | n/a | n/a | Effective against vascularized dermal equivalent for severe trauma cases | [114] |
Fibrin/hyaluronan gels | Tracheal defects | Cartilage regeneration | Chondrocytes from rabbit | Female rabbits | n/a | n/a | No graft rejection recorded | [115] |
3D fibrin constructs | Skin grafting | Dermo-epidermal skin substitutes | Adipose-derived cells | Immuno-incompetent female nu/nu rats | n/a | n/a | Successful prevascularizion of wound bed | [116] |
Fibrin/hyaluronic acid (HA) hydrogel with poly(l-lactic-co-glycolic acid) (PLGA) | Reconstruction of trachea | Thyroid/laryngeal malignancies | Allogeneic chondrocytes | New Zealand white male rabbits | n/a | n/a | Successful neocartilage formation with minimal granulation tissue | [117] |
Poly(l-lactide) modified fibrin | Ascorbic acid rich skin constructs | Heart valve | Human dermal fibroblasts | n/a | n/a | n/a | Promoted collagen production in the cells | [118] |
Thrombin/fibrinogen embedded skin explants | Skin substitute | Skin explants in wound repair | Skeletal muscle explants | n/a | n/a | n/a | Excellent cell outgrowth from skin explants onto dermal substitute | [119] |